Clinical Trial Update: Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy plus stereotactic body radiation therapy and nelfinavir mesylate in locally advanced pancreatic cancer has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Nelfinavir mesylate (nelfinavir)
• Stereotactic Body Radiation Therapy (SBRT)

Snippet

Sponsor: University of Nebraska | Conditions: Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-11-15